ES2068800T1 - Preparacion farmaceutica en forma de un comprimido efervescente o de desintegracion o un granulado soluble al instante, y procedimiento para su produccion. - Google Patents
Preparacion farmaceutica en forma de un comprimido efervescente o de desintegracion o un granulado soluble al instante, y procedimiento para su produccion.Info
- Publication number
- ES2068800T1 ES2068800T1 ES93902180T ES93902180T ES2068800T1 ES 2068800 T1 ES2068800 T1 ES 2068800T1 ES 93902180 T ES93902180 T ES 93902180T ES 93902180 T ES93902180 T ES 93902180T ES 2068800 T1 ES2068800 T1 ES 2068800T1
- Authority
- ES
- Spain
- Prior art keywords
- active ingredient
- pct
- matrix
- amount
- effervescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
LA PREPARACION FARMACEUTICA EN LA FORMA DE UNA TABLETA EFERVESCENTE Y/O DESINTEGRABLE O EN UN GRANULADO INSTANTANEO CONTIENE AL MENOS UN AGENTE IRRITANTE PARA EL GUSTO Y AL MENOS UNA MATRIZ DE RETRASO DE LIBERACION DEL AGENTE QUE ESTA UNIDO INTIMAMENTE CON LAS PARTICULAS DEL AGENTE O BIEN LAS ENVUELVE Y LAS APLICA A UN SUBSTRATO. LA PREPARACION EN SOLUCION ACUOSA A TEMPERATURA AMBIENTE LIBERA COMO MAXIMO 65 Y CON PREFERENCIA 50 % DEL AGENTE DENTRO DE APROXIMADAMENTE 2 MINUTOS, PERO EN 0,1 N HCI A 38 % DEL AGENTE EN UN TIEMPO COMO MAXIMO DE 20 Y CON PREFERENCIA DE 15 MINUTOS. LA MATRIZ CONTIENE PREFERENTEMENTE AL MENOS UN ESTER DE ACIDO GRASO Y/O UNA CERA, CON PREFERENCIA CON UN PUNTO DE FUSION ENTRE 30 Y 45, ESPECIALMENTE ENTRE 32 Y 35 MENOS UN DERIVADOS DE CELULOSA Y/O Y AL MENOS UN ESTER ACIDO POLIMETACRILATO. LA CANTIDAD DEL AGENTE SE ENCUENTRA POR DEBAJO DE 60 Y CON PREFERENCIA POR DEBAJO DE 10 MG, DE FORMA QUE EN LA MATRIZ SE DISPONE DE 1 HASTA 10, CON PREFERENCIA 3 HASTA 5 VECES DE LACANTIDAD CORRESPONDIENTE AL AGENTE POR TABLETA O DOSIS DE GRANULADO. PARA EL TRATAMIENTO DE DIARREA MEDIANTE AL MENOS LIPERAMIDA, LA MATRIZ CONTIENE TAMBIEN UNA MEZCLA Y CANTIDAD DE SALES ALCALINAS Y/O ALCALINOTERREAS, CON PREFERENCIA SALES ORGANICAS Y CLORUROS QUE COMPENSAN LA PERDIDA DE ELECTROLITOS EN EL CUERPO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92100441 | 1992-01-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2068800T1 true ES2068800T1 (es) | 1995-05-01 |
| ES2068800T3 ES2068800T3 (es) | 1995-12-16 |
Family
ID=8209237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93902180T Expired - Lifetime ES2068800T3 (es) | 1992-01-13 | 1993-01-12 | Preparacion farmaceutica en forma de un comprimido efervescente y/o de descomposicion, o de un granulado instantaneo, asi como procedimiento para su fabricacion. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5587179A (es) |
| EP (1) | EP0620731B1 (es) |
| JP (1) | JPH07506336A (es) |
| AT (1) | ATE128028T1 (es) |
| AU (1) | AU668375B2 (es) |
| CA (1) | CA2127352C (es) |
| CZ (1) | CZ283351B6 (es) |
| DE (1) | DE59300632D1 (es) |
| DK (1) | DK0620731T3 (es) |
| ES (1) | ES2068800T3 (es) |
| FI (1) | FI110353B (es) |
| GR (2) | GR950300005T1 (es) |
| MX (1) | MX9300110A (es) |
| PL (1) | PL173676B1 (es) |
| WO (1) | WO1993013760A1 (es) |
| ZA (1) | ZA93215B (es) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5395627A (en) * | 1992-09-04 | 1995-03-07 | Akzo N.V. | Pharmaceutical granulate |
| DE4403943A1 (de) * | 1994-02-08 | 1995-08-10 | Hexal Pharma Gmbh | Orale Azrneimittelzubereitung mit Diclofenac-Natrium |
| TW466119B (en) * | 1994-02-28 | 2001-12-01 | Janssen Pharmaceutica Nv | Film coated tablet of paracetamol and domperidone |
| GB9421836D0 (en) * | 1994-10-28 | 1994-12-14 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
| US5837287A (en) * | 1994-10-28 | 1998-11-17 | R P Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| US5807577A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
| GB9710767D0 (en) * | 1996-06-26 | 1997-07-23 | On Ninh | Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same |
| BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
| US5843477A (en) * | 1997-09-30 | 1998-12-01 | Bayer Corporation | Lubricants for use in tabletting |
| US5904937A (en) * | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
| DE19814257A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
| DE19814256A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
| DE19822036A1 (de) * | 1998-05-15 | 1999-11-18 | Bayer Ag | Brausezubereitungen |
| GB9816899D0 (en) | 1998-08-05 | 1998-09-30 | Boots Co Plc | Therapeutic agents |
| US7001612B2 (en) | 1998-08-26 | 2006-02-21 | All Sun Hsf Company Limited | Composition for the relief of heat stress |
| US6235322B1 (en) * | 1999-03-09 | 2001-05-22 | Mintech, Inc. | Highly soluble and stable mineral supplements containing calcium and magnesium |
| AP2002002410A0 (en) * | 1999-08-04 | 2002-03-31 | Ranbaxy Laboratories Ltd | Hydrodynamically Balancing Oral Drug Delivery System |
| US6284270B1 (en) | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
| DE60133723T2 (de) * | 2000-02-28 | 2009-07-02 | PharmaKodex Ltd., Chippenham | Verabreichungssystemen für oral anzuwendende arzneimittel |
| AU2001275043A1 (en) | 2000-05-31 | 2001-12-11 | Drugtech Corporation | Mineral supplement |
| GB0222612D0 (en) * | 2002-09-30 | 2002-11-06 | Univ Gent | Controlled delivery system for bioactive substances |
| WO2004032906A1 (en) * | 2002-10-11 | 2004-04-22 | Depomed Development, Ltd. | Gastro-retentive levodopa delivery form |
| JP4601271B2 (ja) * | 2003-08-01 | 2010-12-22 | 大洋薬品工業株式会社 | 圧縮成形製剤およびその製造方法 |
| WO2005021056A1 (en) * | 2003-08-21 | 2005-03-10 | Cns, Inc. | Effervescent delivery system |
| US8216610B2 (en) * | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
| JO3352B1 (ar) * | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
| US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
| JP2009517346A (ja) | 2005-11-28 | 2009-04-30 | イメイジノット ピーティーワイ エルティーディー | 治療用化合物の経口送達系 |
| EP1902708A1 (de) | 2006-09-25 | 2008-03-26 | Losan Pharma GmbH | Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung |
| CN101084881B (zh) * | 2007-06-23 | 2012-08-29 | 淮北辉克药业有限公司 | 靶向速释泡腾制剂及其制备方法 |
| CA2704209C (en) | 2007-10-31 | 2017-02-28 | Mcneil-Ppc, Inc. | Orally disintegrative dosage form |
| US8313768B2 (en) | 2009-09-24 | 2012-11-20 | Mcneil-Ppc, Inc. | Manufacture of tablet having immediate release region and sustained release region |
| US8858210B2 (en) | 2009-09-24 | 2014-10-14 | Mcneil-Ppc, Inc. | Manufacture of variable density dosage forms utilizing radiofrequency energy |
| US9610224B2 (en) | 2009-09-24 | 2017-04-04 | Johnson & Johnson Consumer Inc. | Manufacture of tablet in a die utilizing powder blend containing water-containing material |
| US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
| US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
| US20150366823A1 (en) | 2013-02-06 | 2015-12-24 | Hermes Arzneimittel Gmbh | Pharmaceutical compositions incorporating low-dose drugs |
| KR20160107254A (ko) | 2014-01-10 | 2016-09-13 | 존슨 앤드 존슨 컨수머 인코포레이티드 | 고주파 및 손실 코팅된 입자를 사용하여 정제를 제조하는 방법 |
| WO2015193485A1 (en) | 2014-06-20 | 2015-12-23 | Hermes Arzneimittel Gmbh | Taste-masked oral pharmaceutical composition |
| US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4289751A (en) * | 1979-06-29 | 1981-09-15 | Merck & Co., Inc. | Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof |
| US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
| US4539198A (en) * | 1983-07-07 | 1985-09-03 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
| HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
| DE3440288A1 (de) * | 1984-11-05 | 1986-05-07 | Gergely, Gerhard, Dr.-Ing., Wien | Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung |
| DE3524003A1 (de) * | 1985-07-04 | 1987-01-08 | Heumann Ludwig & Co Gmbh | Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung |
| US4832956A (en) * | 1985-09-25 | 1989-05-23 | Gerhard Gergely | Disintegrating tablet and process for its preparation |
| US4753800A (en) * | 1985-10-04 | 1988-06-28 | Warner-Lambert Company | Medicament adsorbates and their preparation |
| NZ231281A (en) * | 1988-11-08 | 1991-01-29 | Takeda Chemical Industries Ltd | Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol |
| GB8908361D0 (en) * | 1989-04-13 | 1989-06-01 | Beecham Group Plc | Composition |
-
1993
- 1993-01-11 MX MX9300110A patent/MX9300110A/es not_active IP Right Cessation
- 1993-01-12 US US08/256,503 patent/US5587179A/en not_active Expired - Lifetime
- 1993-01-12 AT AT93902180T patent/ATE128028T1/de active
- 1993-01-12 CZ CZ941605A patent/CZ283351B6/cs not_active IP Right Cessation
- 1993-01-12 DK DK93902180.4T patent/DK0620731T3/da active
- 1993-01-12 JP JP5512137A patent/JPH07506336A/ja active Pending
- 1993-01-12 ES ES93902180T patent/ES2068800T3/es not_active Expired - Lifetime
- 1993-01-12 DE DE59300632T patent/DE59300632D1/de not_active Expired - Lifetime
- 1993-01-12 WO PCT/EP1993/000055 patent/WO1993013760A1/de active IP Right Grant
- 1993-01-12 CA CA002127352A patent/CA2127352C/en not_active Expired - Fee Related
- 1993-01-12 PL PL93304677A patent/PL173676B1/pl not_active IP Right Cessation
- 1993-01-12 EP EP93902180A patent/EP0620731B1/de not_active Expired - Lifetime
- 1993-01-12 AU AU33492/93A patent/AU668375B2/en not_active Ceased
- 1993-01-13 ZA ZA93215A patent/ZA93215B/xx unknown
-
1994
- 1994-07-12 FI FI943315A patent/FI110353B/fi active
-
1995
- 1995-02-28 GR GR950300005T patent/GR950300005T1/el unknown
- 1995-10-18 GR GR950402909T patent/GR3017806T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR950300005T1 (en) | 1995-02-28 |
| US5587179A (en) | 1996-12-24 |
| WO1993013760A1 (de) | 1993-07-22 |
| AU3349293A (en) | 1993-08-03 |
| CZ283351B6 (cs) | 1998-03-18 |
| FI110353B (fi) | 2002-12-31 |
| FI943315A0 (fi) | 1994-07-12 |
| ATE128028T1 (de) | 1995-10-15 |
| DE59300632D1 (de) | 1995-10-26 |
| EP0620731B1 (de) | 1995-09-20 |
| JPH07506336A (ja) | 1995-07-13 |
| CA2127352A1 (en) | 1993-07-22 |
| DK0620731T3 (da) | 1996-04-09 |
| FI943315A (fi) | 1994-07-12 |
| GR3017806T3 (en) | 1996-01-31 |
| EP0620731A1 (de) | 1994-10-26 |
| ES2068800T3 (es) | 1995-12-16 |
| AU668375B2 (en) | 1996-05-02 |
| CZ160594A3 (en) | 1994-12-15 |
| MX9300110A (es) | 1994-07-29 |
| ZA93215B (en) | 1993-08-19 |
| PL173676B1 (pl) | 1998-04-30 |
| CA2127352C (en) | 2005-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2068800T1 (es) | Preparacion farmaceutica en forma de un comprimido efervescente o de desintegracion o un granulado soluble al instante, y procedimiento para su produccion. | |
| IL111647A0 (en) | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them | |
| UA26455C2 (uk) | Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта | |
| CA2265766A1 (en) | Rapidly disintegrating pellets | |
| AP1526A (en) | Sertraline salts and sustained-release dosage forms of sertraline. | |
| GR3031135T3 (en) | Compositions containing S(+)-Ibuprofen. | |
| SE8404804D0 (sv) | Forfarande for framstellning av farmaceutiska kompositioner med fordrojd frigoring och med en hog halt aktiv bestandsdel | |
| HUP0105463A2 (hu) | Divalproex-nátriumot tartalmazó szabályozott felszabadulású készítmény | |
| ES2110212T3 (es) | Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion. | |
| HU9603463D0 (en) | Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl) propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients | |
| HK1017615A1 (en) | Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases. | |
| JP2006273849A (ja) | フェノフィブラート含有組成物 | |
| YU20050413A (sh) | Kompozicije oksikodona sa kontrolisanim oslobađanjem | |
| RU94044939A (ru) | Терапевтическая композиция в форме таблеток содержащая парацетамол |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 620731 Country of ref document: ES |